ABT and BSX: Comparing Revenue Performance for Fiscal 2019
ABT or BSX: Which Is a More Attractive Pick in April?(Continued from Prior Part)Revenue guidance In its first-quarter earnings conference call, Abbott Laboratories (ABT) reiterated its YoY organic sales growth rate of 6.5%–7.5% for fiscal 2019.